MedTrace Logo

Efficacy and Tolerability of Enstilar® in Daily Practice

NCT02881346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2019-12-13

No results posted yet for this study

Summary

This study aims to assess how the Enstilar® aerosol foam performs in daily real-life practice with regards to effectiveness and convenience of application to psoriasis plaques on body and extremities. In addition the profiles of patients prescribed Enstilar® will be described, and preceeding, concomitant and follow-up management will be mapped. The study will be conducted in about 100 dermatology clinics all over Germany,

Conditions

Interventions

DRUG

Enstilar®

Once daily application of cutaneous foam to plaques on body and/or extremities

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Sascha Gerdes, Dr.med. · Clinic for Dermatology, Venereology and Allergy, University Clinic Schleswig-Holstein, Campus Kiel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881346 on ClinicalTrials.gov